The Trump administration's cancellation of NIH funding for clinical trials in cancer and other diseases could have disastrous ...

Cutaneous melanoma, the most aggressive form of skin cancer, is characterized by its accumulation of a large number of ...

The hub will evaluate how emerging therapeutics, including GLP-1 agonists, might impact cancer progression and treatment.

Merck & Co said on Thursday that it plans to launch a subcutaneously injected version of its blockbuster cancer immunotherapy ...

Joshua Rabinowitz will direct Princeton’s role in the Weill Cancer Hub East, a collaboration with The Rockefeller University, ...

Sandy Weill on Thursday announced a new $50 million donation to create a cancer research and treatment hub focused on ...

In this interview, News Medical speaks with Olivier Negre, Chief Scientific Officer at Smart Immune, about how immunotherapy ...

First and only immunotherapy to show meaningful overall survival benefit in a Phase 2 trial in patients with advanced ovarian cancer Initiation ...

Lung cancer remains one of the most widespread and deadliest malignant tumors globally, with a particularly high mortality rate among all cancers. Recently, immunotherapy, particularly immune ...

The genetic modification of the Natural Killer (NK) cells, lymphocytes forming part of the body’s immune system, would make it possible to retain their capacity of eliminating tumour cells in solid ...

CERo’s technology works by grafting onto patients’ own T-cells a receptor that binds to a naturally occurring human antigen ...

Bianca Edwards got a second chance from the immunotherapy drug. Picture: Justin Lloyd. “It also meant less time in hospital, because instead of sitting in hospital for hours or overnight ...